VSee Health, Inc. (NASDAQ:VSEE) Short Interest Update

VSee Health, Inc. (NASDAQ:VSEEGet Free Report) was the target of a significant growth in short interest during the month of January. As of January 30th, there was short interest totaling 1,137,627 shares, a growth of 44.0% from the January 15th total of 790,206 shares. Based on an average daily volume of 823,326 shares, the days-to-cover ratio is presently 1.4 days. Based on an average daily volume of 823,326 shares, the days-to-cover ratio is presently 1.4 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in VSee Health stock. HB Wealth Management LLC purchased a new stake in shares of VSee Health, Inc. (NASDAQ:VSEEFree Report) in the third quarter, according to its most recent filing with the SEC. The firm purchased 602,652 shares of the company’s stock, valued at approximately $368,000. HB Wealth Management LLC owned 16.74% of VSee Health at the end of the most recent quarter. 1.01% of the stock is owned by institutional investors and hedge funds.

VSee Health Stock Performance

VSee Health stock opened at $0.35 on Friday. VSee Health has a one year low of $0.31 and a one year high of $2.52. The business has a fifty day moving average of $0.42 and a two-hundred day moving average of $0.65. The company has a market cap of $1.26 million and a P/E ratio of -1.13.

VSee Health (NASDAQ:VSEEGet Free Report) last posted its quarterly earnings results on Friday, November 14th. The company reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.06. The company had revenue of $3.98 million for the quarter, compared to analyst estimates of $4.10 million.

Analysts Set New Price Targets

A number of equities analysts have commented on VSEE shares. Weiss Ratings restated a “sell (e+)” rating on shares of VSee Health in a research report on Wednesday, January 21st. Wall Street Zen upgraded shares of VSee Health to a “sell” rating in a research note on Saturday, December 6th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $5.00.

Get Our Latest Analysis on VSee Health

About VSee Health

(Get Free Report)

VSee Health is a telehealth technology company that develops secure, HIPAA-compliant software solutions for virtual care. The company’s flagship platform offers high-definition video visits, real-time messaging and collaboration tools designed to streamline remote consultations between patients and healthcare providers. VSee’s solutions are built to integrate with electronic health record systems and include features such as digital waiting rooms, screen sharing and file transfer capabilities.

In addition to video conferencing, VSee Health provides remote patient monitoring (RPM) tools that enable clinicians to collect biometric data, such as blood pressure, heart rate and glucose readings, from patients in their homes.

See Also

Receive News & Ratings for VSee Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VSee Health and related companies with MarketBeat.com's FREE daily email newsletter.